Energy balance and carcinogenesis: Underlying pathways and targets for intervention

Current Cancer Drug Targets

Volumn 7, Issue 5, 2007, Pages 484-491

  Hursting, Stephen D ^a,b   Lashinger, Laura M ^a   Colbert, Lisa H ^c   Rogers, Connie J ^d   Wheatley, Karrie W ^a   Nunez, Nomeli P ^a   Mahabir, Somdat ^e   Barrett, J Carl ^f   Forman, Michele R ^e   Perkins, Susan N ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Energy balance; Genomics; Inflammation; Insulin; Insulin like growth factor 1; Leptin; Metabolomics; Molecular carcinogenesis; Obesity; Proteomics

Indexed keywords

ANDROGEN; ESTROGEN; INSULIN; LEPTIN; PROGESTERONE; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN;

CANCER CONTROL; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; DIET; DOWNSTREAM PROCESSING; ENERGY BALANCE; EXERCISE; GENOMICS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLOMICS; NONHUMAN; OBESITY; PROTEOMICS; REVIEW;

ANIMALS; ENERGY METABOLISM; HUMANS; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; SIGNAL TRANSDUCTION;

EID: 34547575781     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800907781386623     Document Type: Review

References (134)

1. USDHHS. U.S. Department of Health and Human Services. National Institutes of Health. Strategic Plan for NIH Obesity Research. A Report of the NIH Obesity Research Task Force. 2004, NIH Publication No. 04-5493.
2. Curry, S. J.; Byers, T.; Hewitt, M. E. Fulfilling the Potential of Cancer Prevention and Early Detection; National Academies Press: Washington, D.C., 2003.
3. Hedley, A.; Ogden, C.; Johnson, C.; Carroll, M.; Curtin, L.; Flegal, K. Prevalence of Overweight and Obesity among US Children, Adolescents, and Adults, 1999-2002. JAMA 2004, 291, 2847-2850.
4. Ogden, C. Advance Data from Vital Health Statistics, CDC, Oct., 2004.
5. Calle, E.; Rodriguez, C.; Walker-Thurmond, K.; Thun, M. Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. N. Engl. J. Med. 2003, 348, 1625-1638.
6. Rundle, A. Molecular Epidemiology of Physical Activity and Cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 227-236.
7. Weindruch, R.; Walford, R. L. The Retardation of Aging and Disease by Dietary Restriction; Charles C. Thomas (Edt.) Springfield, IL, 1988.
8. Hursting, S.; Lavigne, J.; Berrigan, D.; Perkins, S.; Barrett, J. Calorie Restriction, Aging, and Cancer Prevention: Mechanisms of Action and Applicability to Humans. Annu. Rev. Med. 2003, 54, 131-152.
9. Altman, J. Weight in the balance. Neuroendocrinology 2002, 76, 131-136.
10. Schwartz, M.; Woods, S.; Porte, Jr., D.; Seely, R.; Baskin, D. Central Nervous System Control of Food Intake. Nature 2000, 404, 661-671.
11. Bray, G. Obesity is a Chronic, Relapsing Neurochemical Disease. Int. J. Obesity, 2004, 28, 34-38.
12. Seeley, R.; Drazen, D.; Clegg, D. The Critical Role of the Melanocortin System in the Control of Energy Balance. Ann. Rev. Nutr. 2004, 24, 133-149.
13. Zigman, J.; Elmquist, J. Minireview: From Anorexia to Obesity - the Yin and Yang of Body Weight Control. Endocrinology 2003, 144, 3749-3756.
14. deGraaf, C.; Blom, W.; Smeets, P.; Stafleu, A.; Hendriks, H. Biomarkers of Satiation and Satiety. Am. J. Clin. Nutr. 2004, 79, 946-961.
15. Macaulay, V. M. Insulin-like Growth Factors and Cancer. Br. J. Cancer 1992, 65, 311-320.
16. LeRoith, D.; Baserga, R.; Helman, L.; Roberts, C. T., Jr. Insulin-like Growth Factors and Cancer. Ann. Internal Med. 1995, 122, 54-59.
17. Singh, P.; Dai, B.; Yallampalli, U.; Lu, X.; Schroy, P. C. Proliferation and Differentiation of a Human Colon Cancer Cell Line (CaCo2) is Associated with Significant Changes in the Expression and Secretion of Insulin-like Growth Factor (IGF) IGF-II and IGF Binding Protein-4: role of IGF-II. Endocrinology 1996, 137, 1764-1774.
18. Fenton, J. I.; Hord, N. G.; Lavigne, J. L.; Perkins, S. N.; Hursting, S. D. Leptin, Insulin-like Growth Factor-1 and Insulin-like Growth Factor-2 are Mitogens in ApcMin/+ but Not Apc+/+ Colonic Epithelial Cell Lines. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 1646-1652.
19. Buckbinder, L.; Talbott, R.; Velasco-Miguel, S.; Takenaka, I.; Faha, B.; Seizinger, B. R.; Kley, N. Induction of the Growth Inhibitor IGF-Binding Protein 3 by p53. Nature 1995, 377, 646-649.
20. Takahashi, K.; Suzuki, K. Association of Insulin-like Growth-Factor-I-Induced DNA Synthesis with Phosphorylation and Nuclear Exclusion of p53 in Human Breast Cancer MCF-7 Cells. Int. J. Cancer 1993, 55, 453-458.
21. LeRoith, D.; Bondy, C.; Yakar S.; Liu, J. L.; Butler, A. The Somatomedin Hypothesis: 2001. Endocr. Rev. 2001, 22, 53-74.
22. Hursting, S. D.; Switzer, B. R.; French, J. E.; Kari, F. W. The Growth Hormone: Insulin-like Growth Factor 1 Axis is a Mediator of Diet Restriction-Induced Inhibition Of Mononuclear Cell Leukemia in Fischer Rats. Cancer Res. 1993, 53, 2750-2757.
23. Resnicoff, M.; Abraham, D.; Yutanawiboonchai, W.; Rotman, H. L.; Kajstura, J.; Rubin, R.; Zoltick, P.; Baserga, R. The Insulin-like Growth Factor I Receptor Protects Tumor Cells from Apoptosis in Vivo. Cancer Res. 1995, 55, 2463-2469.
24. Dunn, S. E.; Ehrlich, M.; Sharp, N. J.; Reiss, K.; Solomom, G.; Hawkins, R.; Baserga, R.; Barrett, J. C. A Dominant Negative Mutant of the Insulin-like Growth Factor-I Receptor Inhibits the Adhesion, Invasion, and Metastasis of Breast Cancer. Cancer Res. 1998, 58, 3353-3361.
25. Gems, D.; Partridge, L. Insulin/IGF Signalling and Ageing: Seeing the Bigger Picture. Curr. Opin. Genet. Dev. 2001, 11, 287-292.
26. McTiernan, A.; Tworoger, S. S.; Ulrich, C. M.; Yasui, Y.; Irwin, M. L.; Rajan, K. B.; Sorensen, B.; Rudolph, R. E.; Bowen, D.; Stanczyk, F. Z.; Potter, J. D.; Schwartz, R. S. Effects of Moderate Intensity Exercise Intervention on Estrogen Metabolism in Postmenopausal Women. Cancer Res. 2004, 64, 2923-2928.
27. Schmitz, K. H.; Ahmed, R. L.; Yee, D. Effects of a 9-Month Strength Training Intervention on Insulin, Insulin-like Growth Factor (IGF)-I, IGF-Binding Protein (IGFBP)-1, and IGFBP-3 in 30-50 Year Old Women. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1597-1604.
28. Min Mice. Med. Sci. Sports Exerc. 2003, 35, 1662-1669.
29. Calle, E.; Kaaks, R. Overweight, Obesity and Cancer: Epidemiological Evidence and Proposed Mechanisms. Nat. Rev. 2004, 4, 579-591.
30. Yakar, S.; LeRoith, D. Brodt, P. The Role of the Growth Hormone/Insulin-like Growth Factor Axis in Tumor Growth and Progression: Lessons from Animal Models. Cytokine Growth Fac. Rev. 2005, 16, 407-420.
31. Abate, N. Insulin resistance and obesity. The Role of Fat Distribution Pattern. Diabetes Care 1996, 19, 292-294.
32. Grimm, J. Interaction of Physical Activity and Diet: Implications for Insulin-Glucose Dynamics. Public Health Nutr. 1999, 2, 363-368.
33. Engelman, J. A.; Luo, J.; Cantley, L. C. The Evolution of Phosphatidylinositol 3-Kinases as Regulators of Growth and Metabolism. Nat. Rev. Genet. 2006, 7, 606-619.
34. Luo, J.; Manning, B. D.; Cantley, L. C. Targeting the PI3K-Akt Pathway in Human Cancer: Rationale and Promise. Cancer Cell 2003, 4, 257-262.
35. Shaw, R. J.; Cantley, L. C. Ras, PI(3)K and mTOR Signaling Controls Tumor Cell Growth. Nature 2006, 441, 424-430.
36. Vivanco, I.; Sawyers, C. L. The Phosphatidylinositol 3-Kinase AKT Pathway in Human Cancer. Nat. Rev. Cancer 2002, 2, 489-501.
37. Brazil, D. P.; Yang, Z. Z.; Hemmings, B. A. Advances in Protein Kinase B Signalling: AKTion on Multiple Fronts. Trends Biochem. Sci. 2004, 29, 233-242.
38. Guertin, D. A.; Sabatini, D. M. An Expanding Role for mTOR in Cancer. Trends Mol. Med. 2005, 11, 353-361.
39. Lietzke, S. E.; Bose, S.; Cronin, T.; Klarlund, J.; Chawla, A.; Czech, M. P.; Lambright, D. G. Structural Basis of 3-Phosphoinositide Recognition by Pleckstrin Homology Domains. Mol. Cell 2000, 6, 385-394.
40. Hay, N. The Akt-mTOR Tango and its Relevance to Cancer. Cancer Cell 2005, 8, 179-183.
41. Ruggero, D.; Sonenberg, N. The Akt of Translational Control. Oncogene 2005, 24, 7426-7434.
42. Petroulakis, E.; Mamane, Y.; Le Bacquer, O.; Shahbazian, D.; Sonenberg, N. mTOR Signaling: Implications for Cancer and Anticancer Therapy. Br. J. Cancer 2006, 94, 195-199.
43. Wullschleger, S.; Loewith, R.; Hall, M. N. TOR Signaling in Growth and Metabolism. Cell 2006, 124, 471-484.
44. Kwiatkowski, D. J.; Manning, B. D. Tuberous Sclerosis: a GAP at the Crossroads of Multiple Signaling Pathways. Hum. Mol. Genet. 2005, 14(2), R251-R258.
45. Manning, B. D.; Cantley, L. C. United at Last: the Tuberous Sclerosis Complex Gene Products Connect the Phosphoinositide 3-Kinase/Akt Pathway to Mammalian Target of Rapamycin (mTOR) Signalling. Biochem. Soc. Trans. 2003, 31, 573-578.
46. Harrington, L. S.; Findlay, G. M.; Gray, A.; Tolkacheva, T.; Wigfield, S.; Rebholz, H.; Barnett, J.; Leslie, N. R.; Cheng, S.; Shepherd, P. R.; Gout, I.; Downes, C. P.; Lamb, R. F. The TSC1-2 Tumor Suppressor Controls Insulin-PI3K Signaling via Regulation of IRS Proteins. J. Cell Biol. 2004, 166, 213-223.
47. Shah, O. J.; Wang, Z.; Hunter, T. Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies. Curr. Biol. 2004, 14, 1650-1656.
48. Radimerski, T.; Montagne, J.; Hemmings-Mieszczak, M.; Thomas, G. Lethality of Drosophila Lacking TSC Tumor Suppressor Function Rescued by Reducing dS6K Signaling. Genes Dev. 2002, 16, 2627-2632.
49. Carling, D. The AMP-Activated Protein Kinase Cascade-a Unifying System for Energy Control. Trends Biochem. Sci. 2004, 29, 18-24.
50. Hardie, D. G.; Carling, D.; Carlson, M. The AMP-Activated/SNF1 Protein Kinase Subfamily: Metabolic Sensors of the Eukaryotic Cell? Annu. Rev. Biochem. 1998, 67, 821-55.
51. Johnson, L. N.; Noble, M. E.; Owen, D. J. Active and Inactive Protein Kinases: Structural Basis for Regulation. Cell 1996, 85, 149-158.
52. Hawley, S. A.; Boudeau, J.; Reid, J. L.; Mustard, K. J.; Udd, L.; Makela, T. P.; Alessi, D. R.; Hardie, D. G. Complexes between the LKB1 Tumor Suppressor, STRAD Alpha/Beta and MO25 Alpha/Beta are Upstream Kinases in the AMP-Activated Protein Kinase Cascade. J. Biol. 2003, 2, 28.
53. Woods, A.; Johnstone, S. R.; Dickerson, K.; Leiper, F. C.; Fryer, L. G.; Neumann, D.; Schlattner, U.; Wallimann, T.; Carlson, M.; Carling, D. LKB1 is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade. Curr. Biol. 2003, 13, 2004-2008.
54. Hemminki, A.; Markie, D.; Tomlinson, I.; Avizienyte, E.; Roth, S.; Loukola, A.; Bignell, G.; Warren, W.; Aminoff, M.; Hoglund, P.; Jarvinen, H.; Kristo, P.; Pelin, K.; Ridanpaa, M.; Salovaara, R.; Toro, T.; Bodmer, W.; Olschwang, S.; Olsen, A. S.; Stratton, M. R.; de la Chapelle, A.; Aaltonen, L. A. A Serine/Threonine Kinase Gene Defective in Peutz-Jeghers Syndrome. Nature 1998, 391, 184-187.
55. Lizcano, J. M.; Goransson, O.; Toth, R.; Deak, M.; Morrice, N. A.; Boudeau, J.; Hawley, S. A.; Udd, L.; Makela, T. P.; Hardie, D. G.; Alessi, D. R. LKB1 is a Master Kinase that Activates 13 Kinases of the AMPK Subfamily, including MARK/PAR-1. EMBO J. 2004, 23, 833-843.
56. Shaw, R. J.; Bardeesy, N.; Manning, B. D.; Lopez, L.; Kosmatka, M.; DePinho, R. A.; Cantley, L. C. The LKB1 Tumor Suppressor Negatively Regulates mTOR Signaling. Cancer Cell 2004, 6, 91-99.
57. Corradetti, M. N.; Inoki, K.; Bardeesy, N.; DePinho, R. A.; Guan, K. L. Regulation of the TSC Pathway by LKB1: Evidence of a Molecular Link between Tuberous Sclerosis Complex and Peutz-Jeghers Syndrome. Genes Dev. 2004, 18, 1533-1538.
58. Shaw, R. J.; Kosmatka, M.; Bardeesy, N.; Hurley, R. L.; Witters, L. A.; DePinho, R. A.; Cantley, L. C. The Tumor Suppressor LKB1 Kinase Directly Activates AMP-Activated Kinase and Regulates Apoptosis in Response to Energy Stress. Proc. Natl. Acad. Sci. USA 2004, 101, 3329-3335.
59. Eng, C. PTEN: One Gene, Many Syndromes. Hum. Mutat. 2003, 22, 183-198.
60. Inoki, K.; Corradetti, M. N.; Guan, K. L. Dysregulation of the TSC-mTOR Pathway in Human Disease. Nat. Genet. 2005, 37, 19-24.
61. Tee, A. R.; Blenis, J. mTOR, Translational Control and Human Disease. Semin. Cell Dev. Biol. 2005, 16, 29-37.
62. Woods, S.; Seeley, R. J.; Porte, D.; Schwartz, M. W. Signals that Regulate Food Intake and Energy Homeostasis. Science 1998, 280, 1378-1382.
63. Zhang, Y.; Leibel, R. Molecular Physiology of Leptin and its Receptor. Growth Genetics and Hormones 1998, 14(2), 17-35.
64. Lonnqvist, F.; Wennlung, A.; Arner, P. Relationship between Circulating Leptin and Peripheral Fat Distribution in Obese Subjects. Int. J. Obes. Relat. Metab. Disord. 1997, 21(4), 255-260.
65. Montague, C. T.; Prins, J. B.; Sanders, L.; Digby, J. E.; O'Rahilly, S. Depot-and Sex-Specific Differences in Human Leptin mRNA Expression: Implications for the Control of Regional Fat Distribution. Diabetes 1997, 46(3), 342-347.
66. Wilding, J.; Widdowson, P.; Williams, G. Obesity: Neurobiology. Br. Med. Bull. 1997, 53, 286-306.
67. Stattin, P.; Lukanova, A.; Biessy, C.; Soderberg, S.; Palmquist, R.; Kaaks, R.; Olsson, T.; Jellum, E. Obesity and Colon Cancer: Does Leptin Provide a Link? Int. J. Cancer 2004, 109, 149-152.
68. Chang, S.; Hursting, S. D.; Contois, J. H.; Strom, S. S.; Yamamura, Y.; Babaian, R. J.; Troncoso, P.; Scardino, P. S.; Wheeler, T. M.; Amos, C. I.; Spitz, M. R. Leptin and Prostate Cancer. Prostate 2001, 46, 62-67.
69. Saglam, K.; Aydur, E.; Yilmaz, M.; Goktas, S. Leptin Influences Cellular Differentiation and Progression in Prostate Cancer. J. Urol. 2003, 169, 1308-1311.
70. Bouloumie, A.; Drexler, H. C.; Lafontan, M. Leptin, the Product of Ob Gene, Promotes Angiogenesis. Circ. Res. 1998, 83, 1059-1066.
71. Ostlund, R. E.; Yang, J. W.; Klein, S.; Gingerich, R. Relation between Plasma Leptin Concentration and Body Fat, Gender, Diet, Age, and Metabolic Covariates. J. Clin. Endocriol. Metab. 1996, 81(11), 3909-3913.
72. Gonzalez, R. R.; Cherfils, S.; Escobar, M.; Yoo, J. H.; Carino, C.; Styer, A. K.; Sullivan, B. T.; Sakamoto, H.; Olawaiye, A. Serikawa, T.; Lynch, M. P.; Rueda, B. R. Leptin and its Signaling Promotes the Growth of Mammary Tumors and Increases the Expression of Vascular Endothelial Growth Factor (VEGF) and its Receptor Type Two (VEGF-R2). J. Biol. Chem. 2006, 281, 26320-26328.
73. Rajala, M.; Scherer, P. Minireview: The Adipocyte - At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis. Endocrinology 2003, 144, 3765-3773.
74. Loffreda, S.; Yang, S. Q.; Lin, H. Z.; Karp, C. L.; Brengman, M. L.; Wang, D. J.; Klein, A. S .; Bulkley, G. B.; Bao, C.; Noble, P. W.; Lane, M. D.; Diehl, A. M. Leptin Regulates Proinflammatory Immune Responses. FASEB J. 1998, 12, 57-65.
75. Kaaks, R.; Lukanova, A.; Kurzer, M. S. Obesity, Endogenous Hormones and Endometrial Cancer Risk: A Synthetic Review. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1531-1543.
76. Evans, R. M. The Nuclear Receptor Superfamily: A Rosetta Stone for Physiology. Mol. Endocrinol. 2005, 19, 1429-1438.
77. Evans, R.; Barish, G.; Wang, Y. -X. PPARs and the Complex Journey to Obesity. Nat. Med. 2004, 10, 1-7.
78. Coussens, L. M.; Werb, Z. Inflammation and Cancer. Nature 2002, 420, 860-867.
79. Sohal, R. S.; Weindruch, R. Oxidative Stress, Caloric Restriction, and Aging. Science 1996, 273, 59-63.
80. Tilg, H.; Dinarello, C. A.; Mier, J. W. IL-6 and APPs: Anti-Inflammatory and Immunosuppressive Mediators. Immunol. Today 1997, 18(9), 428-432.
81. Dinarello, C. A. The Role of the Interleukin-1-Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1. N. Engl. J. Med. 2000, 343(10), 732-734.
82. Moore, K. W.; O'Garra, A.; de Waal Malefyt, R.; Vieira, P.; Mosmann, T. R. Interleukin-10. Annu. Rev. Immunol. 1993, 11, 165-190.
83. Pretolani, M. Interleukin-10: An Anti-Inflammatory Cytokine with Therapeutic Potential. Clin. Exp. Allergy 1999, 29(9), 1164-1171.
84. Coppack, S. W. Pro-Inflammatory Cytokines and Adipose Tissue. Proc. Nutr. Soc. 2001, 60(3), 349-356.
85. Dandona, P.; Aljada, A.; Bandyopadhyay, A. Inflammation: the Link Between Insulin Resistance, Obesity and Diabetes. Trends Immunol. 2004, 25, 4-7.
86. Weisberg, S. P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R. L.; Ferrante, A. W., Jr. Obesity is Associated with Macrophage Accumulation in Adipose Tissue. J. Clin. Invest. 2003, 112(12), 1796-1808.
87. Xu, H.; Barnes, G. T.; Yang, Q.; Tan, G.; Yang, D.; Chou, C. J.; Sole, J.; Nichols, A.; Ross, J. S.; Tartaglia, L. A.; Chen, H. Chronic Inflammation in Fat Plays a Crucial Role in the Development of Obesity-Related Insulin Resistance. J. Clin. Invest. 2003, 112(12), 1821-1830.
88. Ballou, S. P.; Lozanski, F. B.; Hodder, S.; Rzewnicki, D. L.; Mion, L. C.; Sipe, J. D.; Ford, A. B.; Kushner, I. Quantitative and Qualitative Alterations of Acute-Phase Proteins in Healthy Elderly Persons. Age Ageing 1996, 25(3), 224-230.
89. Paolisso, G.; Rizzo, M. R.; Mazziotti, G.; Tagliamonte, M. R.; Gambardella, A.; Rotondi, M.; Carella, C.; Giugliano, D.; Varricchio, M.; D'Onofrio, F. Advancing Age and Insulin Resistance: Role of Plasma Tumor Necrosis Factor-Alpha. Am. J. Physiol. 1998, 275(2 Pt 1), E294-E299.
90. Bruunsgaard, H.; Jensen, M. S.; Schjerling, P.; Halkjaer-Kristensen, J.; Ogawa, K.; Skinhoj, P.; Pedersen, B. K. Exercise Induces Recruitment of Lymphocytes with an Activated Phenotype and Short Telomeres in Young and Elderly Humans. Life Sci. 1999, 65(24), 2623-2633.
91. Dobbs, R. J.; Charlett, A.; Purkiss, A. G.; Dobbs, S. M.; Weller, C.; Peterson, D. W. Association of Circulating TNF-Alpha and IL-6 with Ageing and Parkinsonism. Acta Neurol. Scand. 1999, 100(1), 34-41.
92. Bruunsgaard, H.; Skinhoj, P.; Pedersen, A. N.; Schroll, M.; Pedersen, B. K. Ageing, Tumour Necrosis Factor-Alpha (TNF-alpha) and Atherosclerosis. Clin. Exp. Immunol. 2000, 121, 255-260.
93. Bruunsgaard, H.; Christiansen, L.; Pedersen, A. N.; Schroll, M.; Jorgensen, T.; Pedersen, B. K. The IL-6 -174G>C Polymorphism is Associated with Cardiovascular Diseases and Mortality in 80-Year-Old Humans. Exp. Gerontol. 2004, 39(2), 255-261.
94. Vgontzas, A. N.; Papanicolaou, D. A.; Bixler, E. O.; Hopper, K.; Lotsikas, A.; Lin, H. M.; Kales, A.; Chrousos, G. P. Sleep Apnea and Daytime Sleepiness and Fatigue: Relation to Visceral Obesity, Insulin Resistance, and Hypercytokinemia. J. Clin. Endocrinol. Metab. 2000, 85(3), 1151-1158.
95. Feingold, K. R.; Grunfeld, C. Role of Cytokines in Inducing Hyperlipidemia. Diabetes 1992, 41(Suppl. 2), 97-101.
96. Winkler, G., F.; Salamon, F.; Harmos, G.; Salamon, D.; Speer, G.; Szekeres, O.; Hajos, P.; Kovacs, M.; Simon, K.; Cseh, K. Elevated Serum Tumor Necrosis Factor-Alpha Concentrations and Bioactivity in Type 2 Diabetics and Patients with Android Type Obesity. Diabetes Res. Clin. Pract. 1998, 42(3), 169-174.
97. Mishima, Y.; Kuyama, A.; Tada, A.; Takahashi, K.; Ishioka, T.; Kibata, M. Relationship between Serum Tumor Necrosis Factor-Alpha and Insulin Resistance in Obese Men with Type 2 Diabetes Mellitus. Diabetes Res. Clin. Pract. 2001, 52(2), 119-123.
98. Harris, T. B.; Savage, P. J.; Tell, G. S.; Haan, M.; Kumanyika, S.; Lynch, J. C. Carrying the Burden of Cardiovascular Risk in Old Age: Associations of Weight and Weight Change with Prevalent Cardiovascular Disease, Risk Factors, and Health Status in the Cardiovascular Health Study. Am. J. Clin. Nutr. 1997, 66(4), 837-844.
99. Volpato, S.; Guralnik, J. M.; Ferrucci, L.; Balfour, J.; Chaves, P.; Fried, L. P.; Harris, T. B. Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women: the Women's Health and Aging Study. Circulation 2001, 103(7), 947-953.
100. Erlinger, T. P.; Platz, E. A.; Rifai, N.; Helzlsouer, K. J. C-Reactive Protein and the Risk of Incident Colorectal Cancer. JAMA 2004, 291(5), 585-590.
101. Lehrer, S.; Diamond, E. J.; Mamkine, B.; Droller, M. J.; Stone, N. N.; Stock, R. G. C-Reactive Protein is Significantly Associated with Prostate-Specific Antigen and Metastatic Disease in Prostate Cancer. BJU Int. 2005, 95(7), 961-962.
102. Smith, J. K.; Dykes, R.; Douglas, J. E.; Krishnaswamy, G.; Berk, S. Long-Term Exercise and Atherogenic Activity of Blood Mononuclear Cells in Persons at Risk of Developing Ischemic Heart Disease. JAMA 1999, 281(18), 1722-1727.
103. Mattusch, F.; Dufaux, B.; Heine, O.; Mertens, I.; Rost, R. Reduction of the Plasma Concentration of C-Reactive Protein Following Nine Months of Endurance Training. Int. J. Sports Med. 2000, 21(1), 21-24.
104. Taaffe, D. R.; Harris, T. B.; Ferrucci, L.; Rowe, J.; Seeman, T. E. Cross-Sectional and Prospective Relationships of Interleukin-6 and C-Reactive Protein with Physical Performance in Elderly Persons: MacArthur Studies of Successful Aging. J. Gerontol. A Biol. Sci. Med. Sci. 2000, 55(12), M709-M715.
105. Fallon, K. E.; Fallon, S. K.; Boston, T. The Acute Phase Response and Exercise: Court and Field Sports. Br. J. Sports Med. 2001, 35(3), 170-173.
106. Geffken, D. F.; Cushman, M.; Burke, G. L.; Polak, J. F.; Sakkinen, P. A.; Tracy, R. P. Association between Physical Activity and Markers of Inflammation in a Healthy Elderly Population. Am. J. Epidemiol. 2001, 153, 242-250.
107. Abramson, J. L.; Vaccarino, V. Relationship between Physical Activity and Inflammation Among Apparently Healthy Middle-Aged and Older US Adults. Arch. Intern. Med. 2002, 162(11), 1286-1292.
108. Wannamethee, S. G.; Lowe, G. D.; Whincup, P. H.; Rumley, A.; Walker, M.; Lennon, L. Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men. Circulation 2002, 105(15), 1785-1790.
109. King, D. E.; Cared, P.; Mainous, A. G., 3rd.; Pearson, W. S. Inflammatory Markers and Exercise: Differences Related to Exercise Type. Med. Sci. Sports Exerc. 2003, 35(4), 575-581.
110. Starkie, R.; Ostrowski, S. R.; Jauffred, S.; Febbraio, M.; Pedersen, B. K. Exercise and IL-6 Infusion Inhibit Endotoxin-Induced TNF-Alpha Production in Humans. FASEB J. 2003, 17(8), 884-886.
111. Keller, C.; Keller, P. et al. Exercise Normalizes Overexpression of TNF-Alpha in Knockout Mice. Biochem. Biophys. Res. Commun. 2004, 321(1), 179-182.
112. Petersen, A. M.; Pedersen, B. K. The Anti-Inflammatory Effect of Exercise. J. Appl. Physiol. 2005, 98(4), 1154-1162.
113. Ostrowski, K.; Rohde, T.; Asp, S.; Schjerling, P.; Pedersen, B. K. Pro- and Anti-Inflammatory Cytokine Balance in Strenuous Exercise in Humans. J. Physiol. 1999, 515(Pt 1), 287-291.
114. Ostrowski, K.; Schjerling, P.; Pedersen, B. K. Physical Activity and Plasma Interleukin-6 in Humans - Effect of Intensity of Exercise. Eur. J. Appl. Physiol. 2000, 83(6), 512-515.
115. Pedersen, B. K.; Hoffman-Goetz, L. Exercise and the Immune System: Regulation, Integration, and Adaptation. Physiol. Rev. 2000, 80(3), 1055-1081.
116. Pedersen, B. K.; Steensberg, A.; Schjerling, P. Muscle-Derived Interleukin-6: Possible Biological Effects. J. Physiol. 2001, 536(Pt 2), 329-337.
117. Suzuki, K.; Nakaji, S.; Yamada, M.; Totsuka, M.; Sato, K.; Sugawara, K. Systemic Inflammatory Response to Exhaustive Exercise. Cytokine Kinetics. Exerc. Immunol. Rev. 2002, 8, 6-48.
118. Febbraio, M. A.; Hiscock, N.; Sacchetti, M.; Fischer, C. P.; Pedersen, B. K. Interleukin-6 is a Novel Factor Mediating Glucose Homeostasis During Skeletal Muscle Contraction. Diabetes 2004, 53(7), 1643-1648.
119. Penkowa, M.; Keller, C.; Keller, P.; Jauffred, S.; Pedersen, B. K. Immunohistochemical Detection of Interleukin-6 in Human Skeletal Muscle Fibers Following Exercise. FASEB J. 2003, 17(14), 2166-2168.
120. Steensberg, A.; Fischer, C. P.; Keller, C.; Moller, K.; Pedersen, B. K. IL-6 Enhances Plasma IL-1ra, IL-10, and Cortisol in Humans. Am. J. Physiol. Endocrinol. Metab. 2003, 285(2), E433-E437.
121. Hiscock, N.; Chan, M. H.; Bisucci, T.; Darby, I. A.; Febbraio, M. A.; Skeletal Myocytes are a Source of Interleukin-6 mRNA Expression and Protein Release During Contraction: Evidence of Fiber Type Specificity. FASEB J. 2004, 18(9), 992-994.
122. Ullum, H.; Haahr, P. M.; Diamant, M.; Palmo, J.; Halkjaer-Kristensen, J.; Pedersen, B. K. Bicycle Exercise Enhances Plasma IL-6 but Does Not Change IL-1 Alpha, IL-1 Beta, IL-6, or TNF-Alpha Pre-mRNA in BMNC. J. Appl. Physiol. 1994, 77(1), 93-97.
123. Moldoveanu, A. I.; Shephard, R. J.; Shek, P. N. Exercise Elevates Plasma Levels but Not Gene Expression of IL-1beta, IL-6, and TNF-Alpha in Blood Mononuclear Cells. J. Appl. Physiol. 2000, 89(4), 1499-1504.
124. Starkie, R. L.; Rolland, J.; Angus, D. J.; Anderson, M. J.; Febbraio, M. A. Circulating Monocytes are Not the Source of Elevations in Plasma IL-6 and TNF-Alpha Levels after Prolonged Running. Am. J. Physiol. Cell Physiol. 2001, 280(4), C769-C774.
125. Schindler, R.; Mancilla, J.; Endres, S.; Ghorbani, R.; Clark, S. C.; Dinarello, C. A. Correlations and Interactions in the Production of Interleukin-6 (IL-6), IL-1, and Tumor Necrosis Factor (TNF) in Human Blood Mononuclear Cells: IL-6 Suppresses IL-1 and TNF. Blood 1990, 75, 40-47.
126. Mizuhara, H.; O'Neill, E.; Seki, N.; Ogawa, T.; Kusunoki, C.; Otsuka, K.; Satoh, S.; Niwa, M.; Senoh, H.; Fujiwara, H. T Cell Activation-Associated Hepatic Injury: Mediation by Tumor Necrosis Factors and Protection by Interleukin 6. J. Exp. Med. 1994, 179(5), 1529-1537.
127. Matthys, P.; Mitera, T.; Heremans, H.; Van Damme, J.; Billiau, A. Anti-Gamma Interferon and Anti-Interleukin-6 Antibodies Affect Staphylococcal Enterotoxin B-Induced Weight Loss, Hypoglycemia, and Cytokine Release in D-Galactosamine-Sensitized and Unsensitized Mice. Infect. Immun. 1995, 63(4), 1158-1164.
128. Lee, C. K.; Klopp, R. G.; Weindruch, R.; Prolla, T. A. Gene Expression Profile of Aging and its Retardation by Caloric Restriction. Science 1999, 285, 1390-1393.
129. Lee, C. K.; Weindruch, R.; Prolla, T. A. Gene-Expression Profile of the Ageing Brain in Mice. Nat. Genet. 2000, 25, 294-297.
130. Weindruch, R.; Kayo, T.; Lee, C. K.; Prolla, T. A. Gene Expression Profiling of Aging Using DNA Microarrays. Mech. Ageing Dev. 2002, 123, 177-193.
131. Pletcher, S. D.; Macdonald, S. J.; Marguerie, R.; Certa, U.; Stearns, S. C.; Goldstein, D. B.; Partridge, L. Genome-Wide Transcript Profiles in Aging and Calorically Restricted Drosophila melanogaster. Curr. Biol. 2002, 12, 712-723.
132. Cao, S. X.; Dhabi, J. M.; Mote, P. L.; Spindler, S. R. Genomic Profiling of Short- and Long-Term Caloric Restriction Effects in the Liver of Aging Mice. Proc. Natl. Acad. Sci. USA 2001, 98, 10630-10635.
133. Dhabi, J. M.; Kim, H.; Mote, P. L.; Beaver, R. J.; Spindler, S. R. Temporal Link between the Phenotypic and Genomic Responses to Caloric Restriction. Proc. Natl. Acad. Sci. USA 2004, 101, 5524-5529.
134. Han, S.; Hickey, M. Microarray Evaluation of Dietary Restriction. J. Nutr. 2005, 135, 1343-1346.